<SEC-DOCUMENT>0001193125-23-256083.txt : 20231013
<SEC-HEADER>0001193125-23-256083.hdr.sgml : 20231013
<ACCEPTANCE-DATETIME>20231013160601
ACCESSION NUMBER:		0001193125-23-256083
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20231010
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231013
DATE AS OF CHANGE:		20231013

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TD SYNNEX CORP
		CENTRAL INDEX KEY:			0001177394
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-COMPUTER & PERIPHERAL EQUIPMENT & SOFTWARE [5045]
		IRS NUMBER:				942703333
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31892
		FILM NUMBER:		231325147

	BUSINESS ADDRESS:	
		STREET 1:		44201 NOBEL DRIVE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		5106563333

	MAIL ADDRESS:	
		STREET 1:		44201 NOBEL DRIVE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNNEX CORP
		DATE OF NAME CHANGE:	20211102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TD SYNNEX CORP
		DATE OF NAME CHANGE:	20211102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNNEX CORP
		DATE OF NAME CHANGE:	20031106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d438723d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:snx="http://www.synnex.com/20231010" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-10-10_to_2023-10-10">TD SYNNEX CORP</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-10-10_to_2023-10-10">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-10-10_to_2023-10-10">0001177394</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="snx-20231010.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-10-10_to_2023-10-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001177394</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-10</xbrli:startDate> <xbrli:endDate>2023-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-10-10_to_2023-10-10">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant To Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt:datemonthdayyearen">October 10, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TD SYNNEX CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-10-10_to_2023-10-10">001-31892</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-10-10_to_2023-10-10">94-2703333</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification Number)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-10-10_to_2023-10-10">44201 Nobel Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-10-10_to_2023-10-10">Fremont</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-10-10_to_2023-10-10">94538</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code) <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-10-10_to_2023-10-10">(510)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-10-10_to_2023-10-10">656-3333</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-10-10_to_2023-10-10">Common stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-10-10_to_2023-10-10">SNX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:exchnameen">The New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;10, 2023, TD SYNNEX Corporation (the &#8220;Company&#8221;) and certain entities managed by affiliates of Apollo Global Management, Inc. and other selling stockholders (collectively, the &#8220;Selling Stockholders&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with the underwriters named in the Underwriting Agreement (the &#8220;Underwriters&#8221;), relating to the secondary public offering (the &#8220;Offering&#8221;) of an aggregate of 6,750,000&#160;shares of the common stock of the Company, par value $0.001 per share (the &#8220;Common Stock&#8221;) sold by the Selling Stockholders. In addition, the Selling Stockholders granted the Underwriters an option to purchase, for a period of 30 calendar days from October 10, 2023, up to an additional 1,012,500 shares of Common Stock. The Offering was completed on October&#160;13, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also pursuant to the Underwriting Agreement, the Company purchased 2,750,000 shares of Common Stock from the Underwriters as part of the Offering at a repurchase price of $95.5135 per share, resulting in a purchase price of approximately $262.7 million (the &#8220;Concurrent Share Repurchase&#8221;). The terms and conditions of the Concurrent Share Repurchase were reviewed and approved by the Audit Committee of the Company&#8217;s board of directors, comprised of independent and disinterested directors of the Company. The Concurrent Share Repurchase was made under the Company&#8217;s existing share repurchase program, and the Company used existing cash on hand to fund the Concurrent Share Repurchase. The Underwriters did not receive any compensation for the shares repurchased by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All the shares in the Offering were sold by the Selling Stockholders. The Company did not receive any of the proceeds from the sale of shares by the Selling Stockholders in the Offering. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the terms of the Underwriting Agreement does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to Exhibit 1.1 incorporated herein by reference. The Offering was made pursuant to shelf registration statements on <span style="white-space:nowrap">Form&#160;S-3</span> (File <span style="white-space:nowrap">No.&#160;333-259270</span> and File <span style="white-space:nowrap">No.&#160;333-274915)</span> filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and which became effective on September&#160;2, 2021 and October&#160;10, 2023, respectively (the &#8220;Registration Statement&#8221;), a prospectus, dated October&#160;10, 2023 included as part of the Registration Statement (File <span style="white-space:nowrap">No.&#160;333-274915)</span> and a preliminary prospectus supplement, dated October&#160;10, 2023 and filed with the SEC on October&#160;10, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d438723dex11.htm">Underwriting Agreement, dated as of October&#160;10, 2023, among TD SYNNEX Corporation, the selling stockholders named therein and the several underwriters named therein. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: October&#160;<span style="text-decoration:underline"></span>13, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">TD SYNNEX CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vetter</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">David Vetter</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d438723dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6,750,000 Shares </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TD Synnex
Corporation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">October&nbsp;10, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp;
Co. LLC, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of
the several </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8194;Underwriters named in Schedule I attached hereto, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 West Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10282 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stockholders named
in Schedule II attached hereto as Selling Stockholders (the &#147;<B><I>Selling Stockholders</I></B>&#148;) of TD Synnex Corporation, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), propose to sell, severally and not jointly, an
aggregate of 6,750,000 shares (the &#147;<B><I>Firm Stock</I></B>&#148;) of the Company&#146;s common stock, par value $0.001 per share (the &#147;<B><I>Common Stock</I></B>&#148;), to the underwriters named in Schedule I (the
&#147;<B><I>Underwriters</I></B>&#148;) attached to this agreement (this &#147;<B><I>Agreement</I></B>&#148;) for whom you are acting as representatives (the &#147;<B><I>Representatives</I></B>&#148;). In addition, the Selling Stockholders propose
to grant to the Underwriters, severally and not jointly, an option to purchase up to an aggregate of 1,012,500 additional shares of the Common Stock on the terms set forth in Section&nbsp;3 (the &#147;<B><I>Option Stock</I></B>&#148;). The Firm
Stock and the Option Stock, if purchased, are hereinafter collectively called the &#147;<B><I>Stock</I></B>&#148;. Subject to the sale of the Firm Stock by the Selling Stockholders to the Underwriters in compliance with the terms of this Agreement,
the Underwriters have agreed to sell to the Company, and the Company has agreed to purchase from the Underwriters (the &#147;<B><I>Share Repurchase</I></B>&#148;) an aggregate of 2,750,000 shares of Common Stock (such shares, the
&#147;<B><I>Repurchase Shares</I></B>&#148;) pursuant to Section&nbsp;3 of this Agreement. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Selling Stockholders by the Underwriters, and the purchase of the
Repurchase Shares from the Underwriters by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As used in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Apollo Entities</I></B>&#148; means the Selling Stockholders included under the heading &#147;Apollo Entities&#148;
in Schedule II hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Applicable Time</I></B>&#148; means 4:00 P.M. (New York City time) on October&nbsp;10,
2023; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Effective Date</I></B>&#148; means the date and time as of which such registration statement, or the
most recent post-effective amendment thereto, if any, became, or is deemed to have become, effective in accordance with the rules and regulations under the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Issuer Free Writing Prospectus</I></B>&#148; means each &#147;issuer free writing prospectus&#148; (as defined in
Rule 433 under the Securities Act) relating to the Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>MiTAC Entities</I></B>&#148; means the Selling
Stockholders included under the heading &#147;MiTAC Entities&#148; in Schedule II hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Preliminary
Prospectus</I></B>&#148; means any preliminary prospectus relating to the Stock included in such registration statement or filed with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) pursuant to Rule 424(b) under the
Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Pricing Disclosure Package</I></B>&#148; means, as of the Applicable Time, the most recent
Preliminary Prospectus, together with the information included in Schedule IV hereto and each Issuer Free Writing Prospectus filed or used by the Company at or before the Applicable Time, other than a road show, that is an Issuer Free Writing
Prospectus but is not required to be filed under Rule 433 under the Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Prospectus</I></B>&#148;
means the final prospectus relating to the Stock, as filed with the Commission pursuant to Rule 424(b) under the Securities Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registration Statement</I></B>&#148; means, collectively, the various parts of such registration statements, each
as amended as of the Effective Date for such part, including any Preliminary Prospectus or the Prospectus, all exhibits to such registration statements and including the information deemed by virtue of Rule 430B under the Securities Act to be part
of such registration statements as of the Effective Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication</I></B>&#148; means any oral or written communication with potential investors undertaken in reliance on Rule 163B under the Securities Act; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication</I></B>&#148; means any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within the meaning of Rule 405 under the Securities Act.<SUP
STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include any documents incorporated by reference therein pursuant to Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act as of the date of such Preliminary Prospectus or the Prospectus, as the case may be. Any reference to
the &#147;most recent Preliminary Prospectus&#148; shall be deemed to refer to the latest Preliminary Prospectus included in the Registration Statement or filed pursuant to Rule 424(b) under the Securities Act prior to or on the date hereof. Any
reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any document filed under the Securities Exchange Act of 1934, as amended (the &#147;<B><I>Exchange Act</I></B>&#148;),
after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and before the date of such amendment or supplement and incorporated by reference in such Preliminary Prospectus or the Prospectus, as the case may be; and any
reference to any amendment to the Registration Statement shall be deemed to include any document filed with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the Effective Date and before the date of such
amendment that is incorporated by reference in the Registration Statement. Any reference herein to the term &#147;Registration Statement&#148; shall be deemed to include any abbreviated registration statement to register additional shares of Common
Stock under Rule 462(b) under the Securities Act (the &#147;<B><I>Rule 462(b) Registration Statement</I></B>&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;<I>Representations, Warranties and Agreements of the Company</I>. The Company represents, warrants and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Registration statements on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-259270</FONT> and <FONT STYLE="white-space:nowrap">333-274915)</FONT> relating to the Stock have (i)&nbsp;been prepared by the Company in conformity with the requirements of the Securities Act and the
rules and regulations of the thereunder; (ii)&nbsp;been filed with the Commission under the Securities Act; and (iii)&nbsp;become effective under the Securities Act. Copies of such registration statements and any amendment thereto have been
delivered by the Company to the Representatives. The Commission has not issued any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending the effectiveness of the Registration Statement, and no
proceeding or examination for such purpose or pursuant to Section&nbsp;8A of the Securities Act has been instituted or threatened by the Commission. The Commission has not notified the Company of any objection to the use of the form of the
Registration Statement or any post-effective amendment thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The Company (i)&nbsp;has not engaged in any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication other than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications with the consent
of the Representatives, with entities that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act, or with institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and
(ii)&nbsp;has not authorized anyone other than the Representatives to engage in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company reconfirms that the Representatives have
been authorized to act on its behalf in undertaking <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed or approved for distribution any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications other than those listed on Schedule VII hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;The Company was not at the time of the initial filing of the Registration Statement and at the earliest time thereafter that the
Company or another offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Stock, is not on the date hereof and will not be on the applicable Delivery Date (as defined below), an
&#147;ineligible issuer&#148; (as defined in Rule 405 under the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Since the time of initial filing of the Registration Statement, the Company has
been, and continues to be, a &#147;well-known seasoned issuer&#148; (as defined in Rule&nbsp;405) eligible to use Form <FONT STYLE="white-space:nowrap">S-3</FONT> for the offering of the Stock. The Company was not an &#147;ineligible issuer&#148;
(as defined in Rule 405) at any such time or date. The Registration Statement is an &#147;automatic shelf registration statement&#148; (as defined in Rule&nbsp;405)<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>and was filed not earlier than
the date that is three years prior to the applicable Delivery Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;The Registration Statement conformed and will conform in
all material respects on the Effective Date and on the applicable Delivery Date, and any amendment to the Registration Statement filed after the date hereof will conform in all material respects when filed, to the requirements of the Securities Act
and the rules and regulations thereunder. The most recent Preliminary Prospectus conformed, and the Prospectus will conform, in all material respects when filed with the Commission pursuant to Rule 424(b) under the Securities Act and on the
applicable Delivery Date to the requirements of the Securities Act and the rules and regulations thereunder. The documents incorporated by reference in any Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated
will conform, when filed with the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as applicable, and the rules and regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;The Registration Statement did not, as of the Effective Date, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading; <I>provided</I> that no representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance
upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section&nbsp;9(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&#8195;The Prospectus will not, as of its date or as of the applicable Delivery Date, contain an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I> that no representation or warranty is made as to information contained in
or omitted from the Prospectus in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in
Section&nbsp;9(f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&#8195;The documents incorporated by reference in any Preliminary Prospectus or the Prospectus did not, and any
further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;The Pricing Disclosure Package did not, as of the Applicable Time, contain an
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I> that no representation or warranty
is made as to information contained in or omitted from the Pricing Disclosure Package made in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter
specifically for inclusion therein, which information is specified in Section&nbsp;9(f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&#8195;Each Issuer Free Writing Prospectus
listed in Schedule V hereto, when taken together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading; <I>provided</I> that no representation or warranty is made as to information contained in or omitted from such Issuer Free Writing Prospectus listed in Schedule V hereto in
reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section&nbsp;9(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&#8195;No Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, as of
the Applicable Time, when taken together with the Pricing Disclosure Package, contained an untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading; <I>provided</I> that no representation or warranty is made as to information contained in or omitted from such Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication listed on Schedule VII hereto, in reliance upon and in conformity with written information furnished to the Company through the
Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section&nbsp;9(f). Each Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications did not, as of the Applicable Time, and at all times through the completion of the public offer and sale of the Stock will not, include
any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of the Securities Act and
the rules and regulations thereunder on the date of first use, and the Company has complied with all prospectus delivery and any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to the Securities Act and rules and
regulations thereunder. The Company has not made any offer relating to the Stock that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives, except as set forth on Schedule VI hereto. The Company
has retained in accordance with the Securities Act and the rules and regulations thereunder all Issuer Free Writing Prospectuses that were not required to be filed pursuant to the Securities Act and the rules and regulations thereunder. The Company
has taken all actions necessary so that any &#147;road show&#148; (as defined in Rule 433 under the Securities Act) in connection with the offering of the Stock will not be required to be filed pursuant to the Securities Act and the rules and
regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&#8195;The Company is not and, as of the applicable Delivery Date after giving effect to the Share Repurchase,
will not be, required to register as an &#147;investment company&#148; as defined in the Investment Company Act of 1940, as amended, and the rules and regulations promulgated thereunder (the &#147;<B><I>Investment Company Act</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&#8195;Neither the Company nor any of its subsidiaries has taken, directly or indirectly,
any action designed to or that has constituted or that might reasonably be expected to cause or result, under the Exchange Act and the rules and regulations promulgated thereunder or otherwise, in stabilization or manipulation of the price of any
securities of the Company to facilitate the sale or resale of the Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&#8195;The Company and each of its subsidiaries have been
duly organized, are validly existing and, if applicable, are in good standing under the laws of their respective jurisdictions in which they are chartered or organized with power and authority to own or lease, as the case may be, and to operate
their properties and conduct their businesses as described in the Pricing Disclosure Package and Prospectus, and are duly qualified to do business as foreign corporations and are in good standing under the laws of each jurisdiction that requires
such qualification, except where the failure to so qualify or to be in good standing or have such power or authority would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the condition (financial or
otherwise), earnings, business or properties of the Company and its subsidiaries, taken as a whole, or on the performance by the Company of its obligations under this Agreement and the Stock (a &#147;<B><I>Material Adverse Effect</I></B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&#8195;The Company has an authorized and outstanding capitalization as set forth in the Pricing Disclosure Package and Prospectus. All
of the outstanding shares of capital stock of the Company and its subsidiaries (including the Stock sold hereunder) have been duly authorized and validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and,
except as otherwise set forth in the Pricing Disclosure Package and Prospectus, all outstanding shares of capital stock of the Company&#146;s subsidiaries are owned by the Company either directly or through wholly owned subsidiaries free and clear
of any security interest, claim, lien or encumbrance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&#8195;The statements in the Pricing Disclosure Package and the Prospectus under
the heading &#147;Material U.S. Federal Income Tax Consequences to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#148; and the statements in Exhibit 4.1 to the Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the most recent fiscal year, insofar as such statements summarize legal matters, agreements, documents or proceedings discussed therein, fairly summarize in all material respects such legal matters,
agreements, documents or proceedings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&#8195;This Agreement has been duly authorized, executed and delivered by the Company, and the
Share Repurchase has been duly authorized by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&#8195;No consent, approval, authorization, filing with or order of any
court or governmental agency or body is required in connection with the transactions contemplated herein (including the Share Repurchase), except such as may be required under the blue sky laws of any jurisdiction in which the Stock is being offered
and sold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&#8195;Except as otherwise disclosed in the Pricing Disclosure Package and the
Prospectus, none of the execution and delivery of this Agreement or the consummation of any other of the transactions contemplated herein (including the Share Repurchase), or the fulfillment of the terms hereof will conflict with, result in a breach
or violation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, (i)&nbsp;the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or comparable constituting
documents of the Company or any of its subsidiaries or (ii)&nbsp;any statute, law, rule, regulation, judgment, order or decree of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction
over the Company or any of its subsidiaries or any of its or their properties, except, in the case of (ii)&nbsp;above, for such breaches, violations or defaults as would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&#8195;The consolidated historical financial statements and schedules of the Company and its consolidated subsidiaries included or
incorporated by reference in the Pricing Disclosure Package and Prospectus present fairly, in all material respects, the financial position, results of operations and cash flows of the Company and its consolidated subsidiaries as of the dates and
for the periods indicated in conformity with generally accepted accounting principles in the United States (&#147;<B><I>GAAP</I></B>&#148;) applied on a consistent basis throughout the periods involved (except as otherwise noted therein); the other
financial data included in the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries. The interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the
Company or any of its subsidiaries or its or their property is pending or, to the knowledge of the Company, threatened that (i)&nbsp;could reasonably be expected to have a material adverse effect on the performance of this Agreement or the
consummation of any of the transactions contemplated hereby (including the Share Repurchase) or (ii)&nbsp;would reasonably be expected to have a Material Adverse Effect, except as set forth in or contemplated in the Pricing Disclosure Package and
the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w)&#8195;Neither the Company nor any of its subsidiaries is in violation or default of (i)&nbsp;any provision of its
charter or bylaws or comparable constituting documents; (ii)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a
party or bound or to which its property is subject; or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree applicable to the Company or any of its subsidiaries of any court, regulatory body, administrative agency, governmental
body, arbitrator or other authority having jurisdiction over the Company or any of its subsidiaries or any of their properties, as applicable, except in the case of (ii)&nbsp;and (iii) above, for such breaches, violations or defaults as would not
reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&#8195;Except as otherwise disclosed in the Pricing Disclosure Package and the
Prospectus, since the end of the period covered by the latest audited financial statements incorporated by reference in the Pricing Disclosure Package: (i)&nbsp;there has been no material adverse change, or any development of the Company or any of
its subsidiaries that would reasonably be expected to result in a material adverse change, in the condition, financial or otherwise, or in the earnings, business, properties, or operations of the Company or its subsidiaries, taken as a whole (a
&#147;<B><I>Material Adverse Change</I></B>&#148;); (ii) the Company and its subsidiaries, considered as one entity, have not, other than in the ordinary course of business, incurred any material liability or obligation, indirect, direct or
contingent, nor, other than in the ordinary course of business, entered into any material transaction or agreement; and (iii)&nbsp;there has been no dividend or distribution of any kind declared, paid or made by the Company or any of its
subsidiaries on any class of capital stock or repurchase or redemption by the Company and its subsidiaries of any class of capital stock except for dividends paid to the Company or its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)&#8195;KPMG LLP, who have certified certain financial statements of the Company and its consolidated subsidiaries and delivered their
report with respect to the audited consolidated financial statements and schedules incorporated by reference in the Pricing Disclosure Package and Prospectus, are independent public accountants with respect to the Company in accordance with local
accounting rules and within the meaning of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)&#8195;The Company and each of its subsidiaries have filed all
applicable tax returns that are required to be filed or have requested extensions thereof (except in any case in which the failure so to file would not reasonably be expected to have a Material Adverse Effect and except as set forth in or
contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto)) and have paid all taxes required to be paid by them and any other assessment, fine or penalty levied against them, to the extent
that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith and for which adequate reserves have been made in accordance with GAAP or as would not reasonably be
expected to have a Material Adverse Effect and except as set forth in or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)&#8195;No labor problem or dispute with the employees of the Company or any of its subsidiaries exists or is threatened or imminent, and
the Company is not aware of any existing or imminent labor disturbance by the employees of the Company or any of its subsidiaries&#146; principal suppliers, contractors or customers, except as would not reasonably be expected to have a Material
Adverse Effect and except as set forth in or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb)&#8195;The Company and each of its subsidiaries are insured by recognized, financially sound and reputable institutions against such
losses and risks and in such amounts and with such deductibles and covering such risks as the Company reasonably believes are adequate and customary for their businesses including, but not limited to, policies covering real and personal property
owned or leased by the Company and its subsidiaries against theft, damage, destruction, acts of terrorism or vandalism and earthquakes. Except as would not reasonably be expected to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have a Material Adverse Effect, (i)&nbsp;all policies of insurance and fidelity or surety bonds insuring the Company and its subsidiaries or their respective businesses, assets, employees,
officers and directors are in full force and effect; (ii)&nbsp;the Company and its subsidiaries are in compliance with the terms of such policies and instruments; (iii)&nbsp;there are no claims by the Company or any of its subsidiaries under any
such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; (iv)&nbsp;neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied
for; and (v)&nbsp;neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as
may be necessary to continue its business at a cost that would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)&#8195;The Company and its subsidiaries possess all licenses, certificates, permits and other authorizations issued by state, federal or
foreign regulatory agencies or bodies necessary to conduct their respective businesses, and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of, or <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with, any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material
Adverse Effect, except as set forth in or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)&#8195;The Company and its subsidiaries, considered as one entity, maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and its subsidiaries&#146; internal controls over financial reporting are effective and the Company and its subsidiaries are not aware of any
material weakness in their internal control over financial reporting. Since the end of the Company&#146;s most recent audited fiscal year, there has been (i)&nbsp;no material weakness in the Company&#146;s internal control over financial reporting
(whether or not remediated) and (ii)&nbsp;no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial
reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee)&#8195;The Company and its subsidiaries, considered as one entity, maintain &#147;disclosure controls and procedures&#148;
(as such term is defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> and Rule <FONT STYLE="white-space:nowrap">15d-15</FONT> under the Exchange Act) designed to ensure that information required to be disclosed by the Company in
reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#146;s rules and forms, including controls and procedures designed to ensure that such
information is accumulated and communicated to the Company&#146;s management, as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their
disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> and Rule <FONT STYLE="white-space:nowrap">15d-15</FONT> of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff)&#8195;The Company and its subsidiaries are (i)&nbsp;in compliance with any and all
applicable laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<B><I>Environmental Laws</I></B>&#148;); (ii) have received and are
in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii)&nbsp;have not received notice of any actual or potential liability under any
Environmental Law, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Environmental Laws, failure to receive required permits, licenses or other approvals, or liability would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, except as set forth in or contemplated in the Pricing Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). Except as set forth in the Pricing Disclosure
Package and the Prospectus, neither the Company nor any of its subsidiaries has been named as a &#147;potentially responsible party&#148; under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg)&#8195;The minimum funding standard under Section&nbsp;302 of the Employee Retirement Income Security Act of 1974, as amended, and the
regulations and published interpretations thereunder (&#147;<B><I>ERISA</I></B>&#148;), has been satisfied by each &#147;pension plan&#148; (as defined in Section&nbsp;3(2) of ERISA) which has been established or maintained by the Company and its
subsidiaries, and the trust forming part of each such plan which is intended to be qualified under Section&nbsp;401 of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder is so qualified; the Company and each of
its subsidiaries have fulfilled their obligations, if any, under Section&nbsp;515 of ERISA; neither the Company nor any of its subsidiaries maintains or is required to contribute to a &#147;welfare plan&#148; (as defined in Section&nbsp;3(1) of
ERISA) which provides retiree or other post-employment welfare benefits or insurance coverage (other than &#147;continuation coverage&#148; (as defined in Section&nbsp;602 of ERISA)); each pension plan and welfare plan established or maintained by
the Company or any of its subsidiaries is in compliance in all material respects with the currently applicable provisions of ERISA; and neither the Company nor any of its subsidiaries has incurred or could reasonably be expected to incur any
withdrawal liability under Section&nbsp;4201 of ERISA, any liability under Section&nbsp;4062, 4063, or 4064 of ERISA, or any other liability under Title IV of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh)&#8195;The subsidiaries listed on <U>Exhibit B</U> attached hereto are the only &#147;significant subsidiaries&#148; (as defined in Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Commission) of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;Neither the Company nor any of its subsidiaries nor any of their respective directors, officers or employees, nor, to the knowledge
of the Company, any agent, controlled affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is (i)&nbsp;currently subject to or the target of any Sanctions (as defined below); or (ii)&nbsp;located,
organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk
People&#146;s Republic and the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic). The Company and each of its subsidiaries have not knowingly engaged in for the past five years, are not now knowingly
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
engaged in, and will not engage in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction is or was the
subject or target of Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj)&#8195;There is and has been no failure on the part of the Company and any of the Company&#146;s
directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, including Section&nbsp;402 relating to loans and Sections 302 and
906 relating to certifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk)&#8195;The Company has implemented and maintains in effect policies and procedures reasonably
designed to promote compliance by it and each of its subsidiaries and their respective directors, officers, employees and agents with the Foreign Corrupt Practices Act of 1977 (the &#147;<B><I>FCPA</I></B>&#148;), and the rules and regulations
thereunder, and all other laws, rules, and regulations of any jurisdiction applicable to the Company and its subsidiaries concerning or relating to bribery, corruption or money laundering (&#147;<B><I>Anti-Corruption Laws</I></B>&#148;) and
applicable economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (i)&nbsp;the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the
Treasury or the U.S. Department of State or (ii)&nbsp;the United Nations Security Council, the European Union or HM Treasury of the United Kingdom, the Government of Canada, the government of Japan or other relevant authority
(&#147;<B><I>Sanctions</I></B>&#148;). Except as disclosed in the Pricing Disclosure Package and the Prospectus, the Company and each of its subsidiaries and, to the knowledge of the Company, their respective officers, employees, directors, agents,
affiliates, and any other person authorized to act on behalf of the Company or any of its subsidiaries, are in compliance with Anti-Corruption Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)&#8195;The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with the
requirements of applicable anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended by the USA PATRIOT ACT of 2001, and the rules and regulations promulgated thereunder, and the anti-money laundering laws
of the various jurisdictions in which the Company and its subsidiaries conduct business (collectively, the &#147;<B><I>Money Laundering Laws</I></B>&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm)&#8195;The Company and its subsidiaries own, possess, license or have other valid and enforceable rights to use on reasonable terms, all
material patents, trade and service marks, trade names, copyrights, domain names (in each case including all registrations and applications to register same), inventions, trade secrets, technology, <FONT STYLE="white-space:nowrap">know-how,</FONT>
and other intellectual property (collectively, the &#147;<B><I>Intellectual Property</I></B>&#148;) used in, held for use in or reasonably necessary for the conduct of the Company&#146;s business as now conducted or as proposed in the Pricing
Disclosure Package and the Prospectus to be conducted (&#147;<B><I>Company IP</I></B>&#148;). Except as set forth in the Pricing Disclosure Package and the Prospectus, (i)&nbsp;no party has been granted an exclusive license to use any portion of
Company IP owned by the Company or any of its subsidiaries; (ii)&nbsp;the Company and each of its subsidiaries own, or have rights to use under license, all Company IP free and clear </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in all material respects of all adverse claims, liens or other encumbrances; (iii)&nbsp;to the knowledge of the Company, there is no material infringement, misappropriation or other violation by
third parties of any Company IP; (iv)&nbsp;there is no pending or, to the Company&#146;s knowledge, threatened action, suit, proceeding or claim by any third party challenging the Company or any of its subsidiaries&#146; rights in or to any Company
IP in any material respect, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; (v)&nbsp;there is no pending or, to the Company&#146;s knowledge, threatened action, suit,
proceeding or claim by any third party challenging the validity, scope or enforceability of any Company IP in any material respect, and the Company is unaware of any facts that would form a reasonable basis for any such action, suit, proceeding or
claim; (vi)&nbsp;there is no pending or, to the Company&#146;s knowledge, threatened action, suit, proceeding or claim by any third party that the Company or any of its subsidiaries&#146; business infringes, misappropriates or otherwise violates any
Intellectual Property of any third party in any material respect, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; and (vii)&nbsp;to the knowledge of the Company, there is no
valid and subsisting patent or published patent application that would preclude the Company or any of its subsidiaries, in any material respect, from practicing any Company IP. The Company and its subsidiaries have at all times taken reasonable
steps in accordance with normal industry practice to maintain the confidentiality of all Company IP, including confidential information and trade secrets, the value of which to the Company or any of its subsidiaries is contingent upon maintaining
the confidentiality thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn)&#8195;(i) Except as disclosed in the Pricing Disclosure Package and the Prospectus, (x)&nbsp;to the
Company&#146;s knowledge, there has been no material security breach or other material compromise of or relating to any of the Company&#146;s or its subsidiaries&#146; information technology and computer systems, networks, hardware, software, data
(including all personal, personally identifiable, sensitive, confidential or regulated data of their respective customers, employees, suppliers, vendors and any third-party data collected, processed, stored, maintained or otherwise used by or on
behalf of them), equipment or technology (collectively, the &#147;<B><I>IT Systems and Data</I></B>&#148;) and (y)&nbsp;the Company and its subsidiaries have not been notified of, and have no knowledge of any event or condition that would reasonably
be expected to result in, any material security breach or other material compromise to the IT Systems and Data; (ii)&nbsp;the Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, policies and contractual obligations relating to the use, processing, privacy and security of the IT Systems and Data and to the protection of the IT Systems
and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (ii), individually or in the aggregate, have a Material Adverse Effect; and (iii)&nbsp;the Company and its subsidiaries have
implemented backup and disaster recovery technology consistent with reasonable industry standards and practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo)&#8195;Other than as
disclosed in the Pricing Disclosure Package and the Prospectus, the Company and each of its subsidiaries have good and marketable title to all the properties and assets reflected as owned in the financial statements incorporated by reference in the
Pricing Disclosure Package and the Prospectus, in each case free and clear of any security interests, mortgages, liens, encumbrances, equities, claims and other defects, except such as do not materially and adversely
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affect the value of such property and/or do not materially interfere with the use made or proposed to be made of such property by the Company or such subsidiary. The real property, improvements,
equipment and personal property held under lease by the Company and its subsidiaries are held under valid and enforceable leases, with such exceptions as are not material and/or do not materially interfere with the use made or proposed to be made of
such real property, improvements, equipment or personal property by the Company or such subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">2.&#8195;<I>Representations,
Warranties and Agreements of the Selling Stockholders</I>. Each Selling Stockholder severally and not jointly represents, warrants and agrees that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Such Selling Stockholder has been to the extent applicable duly organized and is validly existing as a corporation, limited
liability company, public agency, or a limited partnership, as the case may be, in good standing in its jurisdiction of formation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;In the case of the Apollo Entities and Matthew Feng Chiang Miau, such Selling Stockholder is a United States person (as the term is
defined in Section&nbsp;7701(a)(30) of the Internal Revenue Code of 1986, as amended) for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Such Selling Stockholder has good and valid title to the shares of Stock to be sold by such Selling Stockholder hereunder on such
Delivery Date and any &#147;security entitlement&#148; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-501</FONT> of the New York Uniform Commercial Code (the &#147;<B><I>UCC</I></B>&#148;) in respect thereof, free and clear of
all liens, encumbrances, equities or adverse claims, except in the case of the Apollo Entities for any liens, encumbrances, equities or adverse claims arising under (1)&nbsp;the Margin Loan Agreement dated as of March&nbsp;3, 2022 among AP IX Tiger
Holdings, L.P., AP IX Tiger Holdings GP, LLC, the lenders party thereto and Barclays Bank plc (and any refinancing or other modification of such margin loan financing) or (2)&nbsp;the Margin Loan Agreement dated as of March&nbsp;3, 2022 among AP IX
Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML), L.P., AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML)&nbsp;GP, LLC, the lenders party thereto and Barclays Bank plc (and any refinancing or other modification of such
margin loan financing). On each Delivery Date as provided in Section&nbsp;4, such Selling Stockholder will, upon delivery of the shares of Stock to be sold by such Selling Stockholder hereunder on such Delivery Date, have good and valid title to
such shares of Stock and any &#147;security entitlement&#148; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-501</FONT> of the UCC in respect thereof, free and clear of all liens, encumbrances, equities or adverse claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;Upon payment for the Stock to be sold by such Selling Stockholder, delivery of such Stock, as directed by the Underwriters, to
Cede&nbsp;&amp; Co. (&#147;<B><I>Cede</I></B>&#148;) or such other nominee as may be designated by The Depository Trust Company (&#147;<B><I>DTC</I></B>&#148;), registration of such Stock in the name of Cede or such other nominee and the crediting
of such Stock on the books of DTC to securities accounts of the Underwriters (assuming that neither DTC nor any such Underwriter has notice of any adverse claim (within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-105</FONT> of the
UCC) to such Stock)&nbsp;(i) DTC shall be a &#147;protected purchaser&#148; of such Stock within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-303</FONT> of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
UCC, (ii)&nbsp;under <FONT STYLE="white-space:nowrap">Section&nbsp;8-501</FONT> of the UCC, the Underwriters will acquire a valid security entitlement in respect of such Stock, and (iii)&nbsp;an
action based on an adverse claim, within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-102</FONT> of the UCC, may not be asserted against the Underwriters with respect to such security entitlement. For purposes of this
representation, such Selling Stockholder may assume that when such payment, delivery and crediting occur, (x)&nbsp;such Stock will have been registered in the name of Cede or another nominee designated by DTC, in each case on the Company&#146;s
share registry in accordance with its certificate of incorporation, bylaws and applicable law, (y)&nbsp;DTC will be registered as a &#147;clearing corporation&#148; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-102</FONT> of
the UCC, and (z)&nbsp;appropriate entries to the accounts of the several Underwriters on the records of DTC will have been made pursuant to the UCC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&#8195;Such Selling Stockholder has full right, power and authority, corporate or otherwise, to enter into this Agreement, and, in the case
of the MiTAC Entities, the Power of Attorney (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&#8195;This Agreement has been duly and validly authorized, executed
and delivered by or on behalf of such Selling Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;The sale of the Stock by such Selling Stockholder, the execution,
delivery and performance of this Agreement, and, in the case of the MiTAC Entities, the Power of Attorney, by such Selling Stockholder and the consummation by such Selling Stockholder of the transactions contemplated hereby and thereby do not and
will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which
such Selling Stockholder is a party or by which such Selling Stockholder is bound or to which any of the property or assets of such Selling Stockholder is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT
STYLE="white-space:nowrap">by-laws</FONT> (or similar organizational documents) of such Selling Stockholder, or (iii)&nbsp;result in any violation of any statute or any judgment, order, decree, rule or regulation of any court or governmental agency
or body having jurisdiction over such Selling Stockholder or the property or assets of such Selling Stockholder, except, with respect to clauses (i)&nbsp;and (iii), conflicts, defaults, breaches or violations that would not, individually or in the
aggregate, reasonably be expected to have a material adverse effect on such Selling Stockholder&#146;s ability to perform its obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&#8195;No consent, approval, authorization or order of, or filing or registration with, any court or governmental agency or body having
jurisdiction over such Selling Stockholder or the property or assets of such Selling Stockholder is required for the sale of the Stock by such Selling Stockholder, the execution, delivery and performance of this Agreement, and, in the case of the
MiTAC Entities, the Power of Attorney, by such Selling Stockholder and the consummation by such Selling Stockholder of the transactions contemplated hereby and thereby, as applicable, except for the registration of the Stock under the Securities Act
and such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required under the Exchange Act and applicable state or foreign securities laws in connection with the purchase and sale of the Stock by the
Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&#8195;The Pricing Disclosure Package, at the Applicable Time did not, and as of the
Initial Delivery Date and as of each Option Stock Delivery Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The preceding sentence applies only to written information furnished to the Company by such Selling Stockholder expressly for use therein, it being understood and agreed that the only such
information furnished by such Selling Stockholder consists of such Selling Stockholder&#146;s Selling Stockholder Information. Each Underwriter, the Company and such Selling Stockholder agree that the &#147;Selling Stockholder Information&#148; with
respect to a Selling Stockholder consists solely of the information furnished by such Selling Stockholder for use in connection with the offering in the Registration Statement, the Pricing Disclosure Package and the Prospectus, which consists solely
of (i)&nbsp;the name, address and number of shares of Common Stock owned by such Selling Stockholder, before and after the offering, and (ii)&nbsp;the other information with respect to such Selling Stockholder that appears in the table (and
corresponding footnotes) under the caption &#147;Selling Stockholders,&#148; in each case, in the Registration Statement, the Pricing Disclosure Package, the Prospectus or in any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&#8195;Such Selling Stockholder is not prompted to sell shares of Common Stock by any information concerning the Company, including any of
its subsidiaries, that is not set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus.<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&#8195;Such Selling Stockholder has not taken, directly or indirectly, any action that is designed to or that has constituted or that could
reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the shares of the Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&#8195;[Reserved] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&#8195;Neither such Selling Stockholder nor any of its subsidiaries (to the extent applicable), nor any director or officer of such Selling
Stockholder or any of its subsidiaries (to the extent applicable) nor, to the knowledge of such Selling Stockholder, any employee of such Selling Stockholder or any of its subsidiaries (to the extent applicable) or any agent, affiliate or other
person associated with or acting on behalf of such Selling Stockholder has: (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made any direct or
indirect unlawful payment to any foreign or domestic government official, &#147;foreign official&#148; (as defined in the FCPA) or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of the FCPA, Bribery Act 2010,
as amended, or any other applicable anti-bribery statute or regulation; or (iv)&nbsp;made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any domestic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
government official, foreign official or employee; and such Selling Stockholder has conducted its business in compliance with the FCPA, Bribery Act 2010, and all other applicable anti-bribery
statutes and regulations, and has instituted and maintain policies and procedures reasonably designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. Neither such Selling Stockholder nor any of its
subsidiaries (to the extent applicable) will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment of giving of money, or anything else of value, to any person
in violation of any applicable anti-corruption laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&#8195;The operations of such Selling Stockholder and its subsidiaries (to the
extent applicable) is and has been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Money Laundering Laws and no action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving such Selling Stockholder or any of its subsidiaries (to the extent applicable) with respect to the Money Laundering Laws is pending or, to the knowledge of such Selling Stockholder, threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&#8195;Neither such Selling Stockholder nor any of its subsidiaries (to the extent applicable), directors or officers, nor, to the
knowledge of such Selling Stockholder, any of such Selling Stockholder or any agent, controlled affiliate or other person associated with or acting on behalf of such Selling Stockholder or any of its subsidiaries (to the extent applicable) is
(i)&nbsp;currently subject to or the target of any Sanctions; or (ii)&nbsp;located, organized or resident in a country that is the subject of Sanctions (including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the
<FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic and the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic); and such Selling Stockholder will not directly or indirectly use the proceeds
of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person, or in any country or territory, that
currently is the subject or target of Sanctions or in any other manner that will result in a violation by any person (including any person participating in the transaction whether as an underwriter, advisor, investor or otherwise) of Sanctions. Such
Selling Stockholder has not knowingly engaged in for the past five years, are not now knowingly engaged in, and will not engage in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the
dealing or transaction is or was the subject or target of Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&#8195;The MiTAC Entities have duly and irrevocably executed and
delivered a power of attorney (the &#147;<B><I>Power of Attorney</I></B>&#148;) appointing Frank F. Huang as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> with full power of substitution, and with
full authority to execute and deliver this Agreement and to take such other action as may be necessary or desirable to carry out the provisions hereof on behalf of the MiTAC Entities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;The Power of Attorney have been duly and validly authorized, executed and delivered by or on behalf of the MiTAC Entities and
constitute valid and legally binding obligations of the MiTAC Entities enforceable against the MiTAC Entities in accordance with their terms, subject to (i)&nbsp;the effects of bankruptcy, insolvency, fraudulent conveyance,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reorganization, moratorium and other similar laws relating to or affecting creditors&#146; rights generally, (ii)&nbsp;general equitable principles (whether considered in a proceeding in equity
or at law), and (iii)&nbsp;an implied covenant of good faith and fair dealing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w)&#8195;No stamp duties or other issuance or transfer
taxes are payable by or on behalf of the Underwriters in Taiwan, British Virgin Islands (&#147;BVI&#148;), the United States or any political subdivision or taxing authority thereof solely in connection with (i)&nbsp;the execution, delivery and
performance of this Agreement, (ii)&nbsp;the delivery of the Stock by the MiTAC Entities in the manner contemplated by this Agreement and the Pricing Disclosure Package or (iii)&nbsp;the sale and delivery by the Underwriters of the Stock as
contemplated herein and in the Pricing Disclosure Package. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&#8195;Any final judgment for a fixed or determined sum of money rendered
by any U.S. federal or New York state court located in the State of New York having jurisdiction under its own laws in respect of any suit, action or proceeding against the MiTAC Entities based upon this Agreement would be declared enforceable
against the MiTAC Entities by the courts of Taiwan or BVI, without reconsideration or reexamination of the merits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)&#8195;The choice
of laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of Taiwan and BVI and will be honored by the courts of Taiwan and BVI. The MiTAC Entities have the power to submit, and pursuant to
Section&nbsp;20 of this Agreement, has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each New York state and United States federal court sitting in the City of New York and has validly and irrevocably
waived any objection to the laying of venue of any suit, action or proceeding brought in such court. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)&#8195;The indemnification and
contribution provisions set forth in Section&nbsp;9 hereof do not contravene Taiwanese or BVI law or public policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)&#8195;To the
extent any payment is to be made by the MiTAC Entities pursuant to this Agreement, the MiTAC Entities have access, subject to the laws of Taiwan, to the internal currency market in Taiwan and, to the extent necessary, valid agreements with Taiwanese
commercial banks for purchasing U.S. dollars to make payments of amounts which may be payable under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate
signed by or on behalf of any Selling Stockholder and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Stock shall be deemed to be a representation and warranty by such Selling Stockholder, as
to matters covered thereby, to each Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">3.&#8195;<I>Purchase of the Stock by the Underwriters</I>. On the basis of the
representations, warranties and covenants contained in, and subject to the terms and conditions of, this Agreement, each Selling Stockholder agrees to sell the number of shares of the Firm Stock set forth opposite its name in Schedule II hereto,
severally and not jointly, to the several Underwriters and each of the Underwriters, severally and not jointly, agrees to purchase the number of shares of the Firm Stock set forth opposite that Underwriter&#146;s name in Schedule I hereto. Each
Underwriter shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligated to purchase from the Selling Stockholders that number of shares of the Firm Stock that represents the same proportion of the number of shares of the Firm Stock to be sold by the Selling
Stockholders as the number of shares of the Firm Stock set forth opposite the name of such Underwriter in Schedule I represents to the total number of shares of the Firm Stock to be purchased by all of the Underwriters pursuant to this Agreement.
The respective purchase obligations of the Underwriters with respect to the Firm Stock shall be rounded among the Underwriters to avoid fractional shares, as the Representatives may determine. Subject to the sale of the Firm Stock by the Selling
Stockholders to the Underwriters in compliance with the terms of this Agreement, the Underwriters agree to sell to the Company, and the Company agrees to purchase from the Underwriters, the number of Repurchase Shares specified herein at the price
payable to the Selling Stockholders by the Underwriters for both the Firm Stock and any Option Stock as set forth below in the third paragraph of this Section&nbsp;3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition, each Selling Stockholder grants to the Underwriters an option to purchase up to the number of shares of Option Stock set forth
opposite such Selling Stockholder&#146;s name in Schedule II hereto, severally and not jointly. Such option is exercisable in the event that the Underwriters sell more shares of Common Stock than the number of shares of Firm Stock in the offering
and as set forth in Section&nbsp;4 hereof. Any such election to purchase Option Stock shall be made in proportion to the maximum number of shares of Option Stock to be sold by each Selling Stockholder as set forth in Schedule II hereto. Each
Underwriter agrees, severally and not jointly, to purchase the number of shares of Option Stock (subject to such adjustments to eliminate fractional shares as the Representatives may determine) that bears the same proportion to the total number of
shares of Option Stock to be sold on such Delivery Date as the number of shares of Firm Stock set forth in Schedule I hereto opposite the name of such Underwriter bears to the total number of shares of Firm Stock; <I>provided</I>, <I>however</I>,
that the amount paid by the Underwriters for any Option Stock shall be reduced by an amount per share equal to any dividends declared by the Company and payable on the Firm Stock but not payable on such Option Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The purchase price payable by the Underwriters for both the Firm Stock and any Option Stock is $95.5135 per share. The number of shares of
Firm Stock to be purchased by each Underwriter from the Selling Stockholders at the price to the public set forth in Schedule IV (the &#147;<B><I>Price to Public</I></B>&#148;) shall be based on the same proportion as the number of shares of the
Firm Stock set forth opposite the name of such Underwriter in Schedule I represents to the total number of shares of the Firm Stock to be purchased by all of the Underwriters pursuant to this Agreement, subject to rounding among the Underwriters to
avoid fractional shares, as the Representatives may determine. The number of shares of Firm Stock to be sold by each Selling Stockholder to the Underwriters at the Price to Public shall be based on the same proportion as the number of shares of the
Firm Stock set forth opposite the name of such Selling Stockholder in Schedule II represents to the total number of shares of the Firm Stock to be sold by all of the Selling Stockholders pursuant to this Agreement, subject to rounding among the
Underwriters to avoid fractional shares, as the Representatives may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Selling Stockholders are not obligated to deliver any
of the Firm Stock or Option Stock to be delivered on the applicable Delivery Date, except upon payment for all such Stock to be purchased on such Delivery Date as provided herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">4.&#8195;<I>Delivery of and Payment for the Stock.</I> Delivery of and payment for the Firm
Stock shall be made at 10:00 A.M., New York City time, on the third full business day following the date of this Agreement or at such other date or place as shall be determined by agreement between the Representatives and the Selling Stockholders.
This date and time are sometimes referred to as the &#147;<B><I>Initial Delivery Date</I></B>&#148;. Delivery of the Firm Stock shall be made to the Representatives for the account of each Underwriter against payment by the several Underwriters
through the Representatives and of the aggregate purchase price of the Firm Stock being sold by the Selling Stockholders to or upon the order of the Selling Stockholders of the purchase price by wire transfer in immediately available funds to the
accounts specified by the Selling Stockholders. Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation of each Underwriter hereunder. The Selling Stockholders
shall deliver the Firm Stock through the facilities of DTC unless the Representatives shall otherwise instruct. In addition, subject to the sale of the Firm Stock by the Selling Stockholders to the Underwriters in compliance with the terms of this
Agreement, payment of the aggregate purchase price of the Repurchase Shares shall be made by the Company to the Underwriters in immediately available funds to an account specified by the Representatives, against delivery of such Repurchase Shares
for the account of the Company at the Initial Delivery Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The option granted in Section&nbsp;3 will expire 30 days after the date of
this Agreement and may be exercised in whole or from time to time in part by written notice being given to the Selling Stockholders by the Representatives; <I>provided</I> that if such date falls on a day that is not a business day, the option
granted in Section&nbsp;3 will expire on the next succeeding business day. Such notice shall set forth the aggregate number of shares of Option Stock as to which the option is being exercised, the names in which the shares of Option Stock are to be
registered, the denominations in which the shares of Option Stock are to be issued and the date and time, as determined by the Representatives, when the shares of Option Stock are to be delivered; <I>provided, however</I>, that this date and time
shall not be earlier than the Initial Delivery Date nor earlier than the second business day after the date on which the option shall have been exercised nor later than the fifth business day after the date on which the option shall have been
exercised. Each date and time the shares of Option Stock are delivered is sometimes referred to as an &#147;<B><I>Option Stock Delivery Date</I></B>&#148;, and the Initial Delivery Date and any Option Stock Delivery Date are sometimes each referred
to as a &#147;<B><I>Delivery Date</I></B>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Delivery of the Option Stock by the Selling Stockholders and payment for the Option
Stock by the several Underwriters through the Representatives shall be made at 10:00&nbsp;A.M., New York City time, on the date specified in the corresponding notice described in the preceding paragraph or at such other date or place as shall be
determined by agreement between the Representatives and the Selling Stockholders. On each Option Stock Delivery Date, the Selling Stockholders shall deliver, or cause to be delivered, the Option Stock, to the Representatives for the account of each
Underwriter, against payment by the several Underwriters through the Representatives and of the respective aggregate purchase prices of the Option Stock being sold by the Selling Stockholders to or upon the order of the Selling Stockholders of the
purchase price by wire transfer in immediately available funds to the accounts specified by the Selling Stockholders. Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the
obligation of each Underwriter hereunder. The Selling Stockholders shall deliver the Option Stock through the facilities of DTC unless the Representatives shall otherwise instruct. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;<I>Further Agreements of the Company and the Underwriters</I>. (a)&nbsp;The Company
agrees: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;To prepare the Prospectus in a form approved by the Representatives and to file such Prospectus pursuant
to Rule 424(b) under the Securities Act not later than the Commission&#146;s close of business on the second business day following the execution and delivery of this Agreement; to make no further amendment or any supplement to the Registration
Statement or the Prospectus prior to the last Delivery Date except as provided herein; to advise the Representatives, promptly after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement or the
Prospectus has been filed and to furnish the Representatives with copies thereof upon reasonable written request; to advise the Representatives, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any
order preventing or suspending the use of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus, of the suspension of the qualification of the Stock for offering or sale in any jurisdiction, of the initiation or
threatening of any proceeding or examination for any such purpose or pursuant to Section&nbsp;8A of the Securities Act, or any notice from the Commission objecting to the use of the form of Registration Statement or any post-effective amendment
thereto, or of any request by the Commission for the amending or supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for additional information; and, in the event of the issuance of any stop order or
of any order preventing or suspending the use of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or suspending any such qualification, to use promptly its reasonable best efforts to obtain its withdrawal of such
order. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;Upon written request, to furnish promptly to each of the Representatives and to counsel for the
Underwriters a signed copy of the Registration Statement as originally filed with the Commission, and each amendment thereto filed with the Commission, including all consents and exhibits filed therewith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;To deliver, upon written request, promptly to the Representatives such number of the following documents as the
Representatives shall reasonably request: (A)&nbsp;conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding exhibits other than this Agreement and the computation of
per share earnings), (B) each Preliminary Prospectus, the Prospectus and any amended or supplemented Prospectus, (C)&nbsp;each Issuer Free Writing Prospectus and (D)&nbsp;any document incorporated by reference in any Preliminary Prospectus or the
Prospectus; and, if the delivery of a prospectus is required at any time after the date hereof in connection with the offering or sale of the Stock and if at such time any events shall have occurred as a result of which the Pricing Disclosure
Package or the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made when such Prospectus is delivered, not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
misleading, or, if for any other reason it shall be necessary to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in
order to comply with the Securities Act, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representatives
may from time to time reasonably request of an amended or supplemented Prospectus that will correct such statement or omission or effect such compliance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&#8195;To file as promptly as practicable with the Commission any amendment or supplement to the Registration Statement or
the Prospectus that may, in the judgment of the Company, be required by the Securities Act or requested by the Commission in connection with the offering or sale of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&#8195;Prior to filing with the Commission any amendment or supplement to the Registration Statement, the Prospectus, any
document incorporated by reference in the Prospectus or any amendment to any document incorporated by reference in the Prospectus, to furnish a copy thereof to the Representatives and counsel for the Underwriters and obtain the consent of the
Representatives to the filing (such consent not to be unreasonably withheld, conditioned or delayed). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&#8195;Not to
make any offer relating to the Stock that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives (such consent not to be unreasonably withheld, conditioned or delayed). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&#8195;To comply with all applicable requirements of Rule 433 under the Securities Act with respect to any Issuer Free
Writing Prospectus. If at any time after the date hereof any events shall have occurred as a result of which any Issuer Free Writing Prospectus, as then amended or supplemented, would conflict with the information in the Registration Statement, the
most recent Preliminary Prospectus or the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading, or, if for any other reason it shall be necessary to amend or supplement any Issuer Free Writing Prospectus, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without
charge to each Underwriter as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Issuer Free Writing Prospectus that will correct such conflict, statement or omission or effect such compliance.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&#8195;To make generally available to the Company&#146;s security holders and to deliver to the Representatives as
soon as practicable, but in any event not later than 16 months after the effective date of the registration statement (as defined in Rule 158(c) under the Securities Act), an earnings statement of the Company and its subsidiaries (which need not be
audited) complying with Section&nbsp;11(a) of the Securities Act and the rules and regulations thereunder (including, at the option of the Company, Rule 158), which may be satisfied by filing on the Commission&#146;s Electronic Data Gathering
Analysis and Retrieval system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&#8195;Promptly from time to time to take such action as the
Representatives may reasonably request to use reasonable best efforts to qualify the Stock for offering and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives may reasonably request and to comply with such laws
so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Stock; <I>provided</I>, that in connection therewith the Company shall not be required to
(A)&nbsp;qualify as a foreign corporation in any jurisdiction in which it would not otherwise be required to so qualify, (B)&nbsp;file a general consent to service of process in any such jurisdiction, or (C)&nbsp;subject itself to taxation in any
jurisdiction in which it would not otherwise be subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&#8195;For a period commencing on the date hereof and ending
on the 60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day after the date of the Prospectus (the &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I></B>&#148;), not to, directly or indirectly, (A)&nbsp;offer for sale,
sell, pledge, lend or otherwise dispose of (or enter into any transaction or device that is designed to, or could be reasonably expected to, result in the disposition by any person of) any shares of Common Stock or securities convertible into or
exercisable or exchangeable for Common Stock (other than (i)&nbsp;Common Stock, options to purchase Common Stock, restricted stock, restricted stock units and any other equity incentive compensation issued pursuant to employee benefit plans,
qualified stock option plans or other employee compensation plans described in the Registration Statement, the Preliminary Prospectus and the Prospectus, (ii)&nbsp;Common Stock issued upon exercise of outstanding options, warrants or rights, whether
or not issued under one of those plans, and Common Stock issued upon the exercise of options or the settlement of restricted stock units granted under such plans or under equity plans or similar plans of companies acquired by the Company in effect
on the date of acquisition, and (iii)&nbsp;the issuance by the Company of shares of Common Stock upon the conversion or exchange of convertible or exchangeable securities outstanding as of the date hereof, including any shares of Common Stock issued
upon the exercise of any warrants issued by the Company and any transfers of shares of Common Stock to the Company upon a &#147;net&#148; or &#147;cashless&#148; exercise of any warrants issued by the Company), (B) enter into any swap or other
derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of such shares of Common Stock, whether any such transaction described in clause (A)&nbsp;or (B) above is to be settled by
delivery of Common Stock or other securities, in cash or otherwise, (C)&nbsp;publicly file or cause to be publicly filed a registration statement, including any amendments thereto, with respect to the registration of any shares of Common Stock or
securities convertible, exercisable or exchangeable into Common Stock or any other securities of the Company (other than any registration statement on Form <FONT STYLE="white-space:nowrap">S-8),</FONT> or (D)&nbsp;publicly disclose the intention to
do any of the foregoing, in each case, without the prior written consent of the Representatives on behalf of the Underwriters, and to cause each officer and director of the Company set forth on Schedule III hereto and the Selling Stockholders to
furnish to the Representatives, prior to the Initial Delivery Date, a letter or letters, substantially in the form of Exhibit A hereto (the &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</I></B>&#148;). For the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
avoidance of doubt and notwithstanding anything herein to the contrary, nothing in this Agreement shall preclude the Company from establishing an issuer trading plan pursuant to Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the repurchase of shares of Common Stock or (B)&nbsp;the repurchase of shares of Common Stock by the Company pursuant to an issuer <FONT STYLE="white-space:nowrap">10b5-1</FONT>
trading plan in existence as of the date hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&#8195;To pay the required Commission filing fees relating to the
Stock within the time required by Rule 456(b)(1) under the Securities Act without regard to the proviso in clause (i)&nbsp;therein and otherwise in accordance with Rules 456(b) and 457(r) under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&#8195;[Reserved] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&#8195;[Reserved] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&#8195;If the Company elects to rely upon Rule 462(b) under the Securities Act, the Company shall file a Rule 462(b)
Registration Statement with the Commission in compliance with Rule 462(b) under the Securities Act by 10:00 P.M., Washington, D.C. time, on the date of this Agreement, and the Company shall at the time of filing pay the Commission the filing fee for
the Rule 462(b) Registration Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 3a(c) of the Commission&#146;s Informal and Other Procedures (16 CFR 202.3a). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv)&#8195;If at any time following the distribution of any Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication there occurred or occurs an event or development as a result of which such Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and, if requested by the Representatives, will promptly amend or supplement, at its
own expense, such Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication to eliminate or correct such untrue statement or omission. The Company will promptly notify the
Representatives of (A)&nbsp;any distribution by the Company of Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications and (B)&nbsp;any request by the Commission for information
concerning the Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi)&#8195;The Company and its affiliates will not take, directly or indirectly, any action designed to or that has
constituted or that reasonably would be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii)&#8195;The Company will deliver to each Underwriter (or its agent), on or prior to the date of execution of this
Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers or applicable exemption certificate (the &#147;<B><I>FinCEN Certification</I></B>&#148;), together with copies of identifying
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
documentation, of the Company and the Company undertakes to provide such additional supporting documentation as each Underwriter may reasonably request in connection with the verification of the
FinCEN Certification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Each Underwriter severally agrees that such Underwriter shall not include any &#147;issuer
information&#148; (as defined in Rule 433 under the Securities Act) in any &#147;free writing prospectus&#148; (as defined in Rule 405 under the Securities Act) used or referred to by such Underwriter without the prior consent of the Company (any
such issuer information with respect to whose use the Company has given its consent, &#147;<B><I>Permitted Issuer Information</I></B>&#148;); <I>provided</I> that (i)&nbsp;no such consent shall be required with respect to any such issuer information
contained in any document filed by the Company with the Commission prior to the use of such free writing prospectus, and (ii) &#147;issuer information&#148;, as used in this Section&nbsp;5(b), shall not be deemed to include information prepared by
or on behalf of such Underwriter on the basis of or derived from issuer information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">6.&#8195;<I>Further Agreements of the Selling
Stockholders</I>. Each Selling Stockholder, severally and not jointly, agrees: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Neither such Selling Stockholder nor any person
acting on behalf of such Selling Stockholder (other than, if applicable, the Company and the Underwriters) shall use or refer to any &#147;free writing prospectus&#148; (as defined in Rule 405 under the Securities Act), relating to the Stock; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&#8195;To deliver to the Representatives prior to the Initial Delivery Date a properly completed and executed United States Treasury
Department Form <FONT STYLE="white-space:nowrap">W-8</FONT> or <FONT STYLE="white-space:nowrap">W-9,</FONT> as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Such
Selling Stockholder will not take, directly or indirectly, any action designed to or that has constituted or that reasonably would be expected to cause or result in the stabilization or manipulation of the price of any security of the Company in
connection with the offering of the Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Such Selling Stockholder will do and perform all things required or necessary to be
done and performed under this Agreement by it prior to each Delivery Date, and to satisfy all conditions precedent to the Underwriters&#146; obligations hereunder to purchase the Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">7.&#8195;<I>Expenses</I><I>.</I> The Company agrees, whether or not the transactions contemplated by this Agreement are consummated or this
Agreement is terminated, to pay all expenses, costs, fees and taxes incident to and in connection with (a)&nbsp;the sale and delivery of the Stock and any stamp duties or other taxes payable in that connection, and the preparation and printing of
certificates for the Stock; (b)&nbsp;the preparation, printing and filing under the Securities Act of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any
Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, and any amendment or supplement thereto; (c)&nbsp;the distribution of the Registration Statement (including any exhibits
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereto), any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication and any amendment or supplement thereto, or any document incorporated by reference therein, all as provided in this Agreement;
(d)&nbsp;the production and distribution of this Agreement, any supplemental agreement among Underwriters, and any other related documents in connection with the offering, purchase, sale and delivery of the Stock; (e)&nbsp;the delivery and
distribution of the Power of Attorney and the fees and expenses of any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact);</FONT></FONT> (f) any required review by the FINRA of the terms of sale of the Stock
(including related reasonable and documented fees and expenses of counsel to the Underwriters in an amount that is not greater than $10,000); (g) the qualification of the Stock under the securities laws of the several jurisdictions as provided in
Section&nbsp;5(a)(ix) and the preparation, printing and distribution of a Blue Sky Memorandum (including related reasonable and documented fees and expenses of counsel to the Underwriters); (h) documented fees and expenses of one firm of counsel to
each Selling Stockholder; (i)&nbsp;the investor presentations on any &#147;road show&#148; or any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, undertaken in connection with the
marketing of the Stock, including, without limitation, expenses associated with any electronic road show and travel and lodging expenses of the representatives and officers of the Company; and (j)&nbsp;all other costs and expenses incident to the
performance of the obligations of the Company and the Selling Stockholders under this Agreement; <I>provided</I> that, except as provided in this Section&nbsp;7 and in Section&nbsp;12, the Underwriters shall pay their own costs and expenses,
including the costs and expenses of their counsel, any transfer taxes on the Stock which they may sell and the expenses of advertising any offering of the Stock made by the Underwriters. The Selling Stockholders agree to pay all underwriting
discounts and commissions in connection with the sale of the Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">8.&#8195;<I>Conditions of Underwriters</I><I>&#146;</I><I>
Obligations</I>. The respective obligations of the Underwriters hereunder are subject to the accuracy, when made and on each Delivery Date, of the representations and warranties of the Company and the Selling Stockholders contained herein, to the
performance by the Company and the Selling Stockholders of their respective obligations hereunder, and to each of the following additional terms and conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Prospectus shall have been timely filed with the Commission in accordance with Section&nbsp;5(a)(i). The Company
shall have complied with all filing requirements applicable to any Issuer Free Writing Prospectus used or referred to after the date hereof; no stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use
of the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no proceeding or examination for such purpose or pursuant to Section&nbsp;8A of the Securities Act shall have been initiated or, to the knowledge of the Company,
threatened by the Commission; and any request of the Commission for inclusion of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with. If the Company has elected to rely upon Rule 462(b)
under the Securities Act, the Rule 462(b) Registration Statement shall have become effective by 10:00 P.M., Washington, D.C. time, on the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;[Reserved] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Pillsbury Winthrop Shaw Pittman LLP shall have furnished to the
Representatives its written opinion, as counsel to the Company, addressed to the Underwriters and dated such Delivery Date, in form and substance reasonably satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;The counsel for each Selling Stockholder shall have furnished to the Representatives its written opinion, as counsel
to such Selling Stockholder, addressed to the Underwriters and dated such Delivery Date, in form and substance satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195; The Representatives shall have received from Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, such
opinion and negative assurance letter, dated such Delivery Date, with respect to the sale of the Stock, the Registration Statement, the Prospectus and the Pricing Disclosure Package and other related matters as the Representatives may reasonably
require, and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;At the time of execution of this Agreement, the Representatives shall have received from KPMG LLP a letter, in form
and substance reasonably satisfactory to the Representatives, addressed to the Underwriters and dated the date hereof (i)&nbsp;confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance
with the applicable requirements relating to the qualification of accountants under Rule&nbsp;2-01 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Commission, and (ii)&nbsp;stating, as of the date hereof (or, with respect to matters
involving changes or developments since the respective dates as of which specified financial information is given in the most recent Preliminary Prospectus, as of a date not more than three business days prior to the date hereof), the conclusions
and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#146; &#147;comfort letters&#148; to underwriters in connection with registered public offerings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&#8195;With respect to the letter of KPMG LLP referred to in the preceding paragraph and delivered to the Representatives
concurrently with the execution of this Agreement (the &#147;<B><I>initial letter</I></B>&#148;), the Representatives shall have received from KPMG LLP a letter (the &#147;<B><I>bring-down letter</I></B>&#148;), addressed to the Underwriters and
dated such Delivery Date (i)&nbsp;confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Commission, (ii)&nbsp;stating, as of the date of the bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified
financial information is given in the Prospectus, as of a date not more than three business days prior to the date of the bring-down letter), the conclusions and findings of such firm with respect to the financial information and other matters
covered by the initial letter, and (iii)&nbsp;confirming in all material respects the conclusions and findings set forth in the initial letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&#8195;The Company shall have furnished to the Representatives a
certificate, dated such Delivery Date, of its Chief Executive Officer or its Chief Financial Officer (solely in their capacities as such) as to such matters as the Representatives may reasonably request, including, without limitation, a statement:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;That the representations, warranties and agreements of the Company in Section&nbsp;1 are true and correct on
and as of such Delivery Date, and the Company has complied with all its agreements contained herein and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to such Delivery Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;That no stop order suspending the effectiveness of the Registration Statement has been issued; and no proceedings
or examination for that purpose or pursuant to Section&nbsp;8A of the Securities Act have been instituted or, to the knowledge of such officers, threatened; and the Commission shall not have notified the Company of any objection to the use of the
form of the Registration Statement or any post-effective amendment thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&#8195;To the effect of
Section&nbsp;8(j) (<I>provided</I> that no representation with respect to the judgment of the Representatives need be made). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195; Each Selling Stockholder shall have furnished to the Representatives on such Delivery Date a certificate, dated such
Delivery Date, signed by, or on behalf of, such Selling Stockholder stating that (i)&nbsp;the representations, warranties and agreements of such Selling Stockholder contained herein are true and correct on and as of such Delivery Date, and
(ii)&nbsp;such Selling Stockholder has complied with all its agreements contained herein and has satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to such Delivery Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&#8195;(i) Except as described in the most recent Preliminary Prospectus, neither the Company nor any of its subsidiaries
shall have sustained, since the date of the latest audited financial statements included or incorporated by reference in the most recent Preliminary Prospectus, any loss or interference with its business, taken as a whole, from fire, explosion,
flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, or (ii)&nbsp;since such date there shall not have been any change in the capital stock (other than as a result
of the exercise or settlement (including any &#147;net&#148; or &#147;cashless&#148; exercises or settlements), if any, of stock options or restricted stock units or the award, if any, of stock options, restricted stock units or restricted stock,
pursuant to the Company&#146;s equity plans) or long-term debt of the Company or any of its subsidiaries, taken as a whole, or any change or effect, or any development involving a prospective change or effect, in or affecting the condition
(financial or otherwise), results of operations, stockholders&#146; equity, properties, management or business of the Company and its subsidiaries, taken as a whole, the effect of which, in any such case described in clause (i)&nbsp;or (ii), is,
individually or in the aggregate, in the judgment of the Representatives, so material and adverse as to make it impracticable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
or inadvisable to proceed with the public offering or the delivery of the Stock being delivered on such Delivery Date on the terms and in the manner contemplated in the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&#8195;On or after the Applicable Time (i)&nbsp;no downgrading shall have occurred in the rating accorded the Company&#146;s
debt securities by any &#147;nationally recognized statistical rating organization&#148;, as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act, and (ii)&nbsp;no such organization shall have publicly
announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company&#146;s debt securities<B>.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;Subsequent to the execution and delivery of this Agreement there shall not have occurred any of the following:
(i)&nbsp;(A) trading in securities generally on any securities exchange that has registered with the Commission under Section&nbsp;6 of the Exchange Act (including the New York Stock Exchange, The Nasdaq Global Select Market, The Nasdaq Global
Market or The Nasdaq Capital Market), or (B)&nbsp;trading in any securities of the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, shall have been suspended
or materially limited or the settlement of such trading generally shall have been materially disrupted or minimum prices shall have been established on any such exchange or such market by the Commission, by such exchange or by any other regulatory
body or governmental authority having jurisdiction, (ii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or state authorities, (iii)&nbsp;the United States shall have become engaged in hostilities,
there shall have been an escalation in hostilities involving the United States or there shall have been a declaration of a national emergency or war by the United States, or (iv)&nbsp;there shall have occurred such a material adverse change in
general economic, political or financial conditions, including, without limitation, as a result of terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United States shall be such) or
any other calamity or crisis, either within or outside the United States, in each case as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the public offering or delivery of the Stock being delivered
on such Delivery Date by the Selling Stockholders on the terms and in the manner contemplated in the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&#8195;[Reserved] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&#8195;The <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements between the Representatives and the officers and
directors of the Company set forth on Schedule III and the Selling Stockholders, delivered to the Representatives on or before the date of this Agreement, shall be in full force and effect on such Delivery Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">9.&#8195;<I>Indemnification and Contribution</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Company hereby agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, officers and
employees and each person, if any, who controls any Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage,
liability or action relating to purchases and sales of Stock), to which that Underwriter, affiliate, director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage,
liability or action arises out of, or is based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in (A)&nbsp;any Preliminary Prospectus, the Registration Statement, the Prospectus or in any amendment or
supplement thereto, (B)&nbsp;any Issuer Free Writing Prospectus or in any amendment or supplement thereto, (C)&nbsp;any Permitted Issuer Information used or referred to in any &#147;free writing prospectus&#148; (as defined in Rule 405 under the
Securities Act) used or referred to by any Underwriter or (D)&nbsp;any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Stock, including any &#147;road
show&#148; (as defined in Rule 433 under the Securities Act) not constituting an Issuer Free Writing Prospectus and any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication
(&#147;<B><I>Marketing Materials</I></B>&#148;) or (ii)&nbsp;the omission or alleged omission to state in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement
thereto or in any Permitted Issuer Information or any Marketing Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter and each such affiliate,
director, officer, employee or controlling person promptly upon demand for any legal or other documented out of pocket expenses reasonably incurred by that Underwriter, affiliate, director, officer, employee or controlling person in connection with
investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; <I>provided</I>, <I>however</I>, that the Company shall not be liable in any such case to the extent that any
such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, the Registration Statement, the Prospectus, any
Issuer Free Writing Prospectus or in any such amendment or supplement thereto or in any Permitted Issuer Information or any Marketing Materials, in reliance upon and in conformity with written information concerning such Underwriter furnished to the
Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information consists solely of the information specified in Section&nbsp;9(f). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The Selling Stockholders, severally and not jointly, shall indemnify and hold harmless each Underwriter, its
affiliates, directors, officers and employees, and each person, if any, who controls any Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any loss, claim, damage or
liability, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of Stock), to which that Underwriter, affiliate, director, officer, employee
or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, the Registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials, any Blue Sky Application
or any &#147;free writing prospectus&#148; (as defined in Rule 405 under the Securities Act) (any such &#147;free writing prospectus&#148; that was prepared by or on behalf of such Selling Stockholder or used or referred to by such Selling
Stockholder in connection with the offering of the Stock in violation of Section&nbsp;6(a) being referred to as a &#147;<B><I>Selling Stockholder Free Writing Prospectus&#148;</I></B>) or (ii)&nbsp;the omission or alleged omission to state in any
Preliminary Prospectus, Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials, any Blue Sky Application or any Selling
Stockholder Free Writing Prospectus, any material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter, its affiliates, directors, officers and employees and each such
controlling person promptly upon demand for any legal or other expenses reasonably incurred by that Underwriter, its affiliates, directors, officers and employees or controlling persons in connection with investigating or defending or preparing to
defend against any such loss, claim, damage, liability or action as such expenses are incurred. The liability of such Selling Stockholder under the indemnity agreement contained in this paragraph shall be limited to an amount equal to the total net
proceeds (before deducting expenses) from the offering of the shares of the Stock purchased under the Agreement received by such Selling Stockholder, as set forth in the table on the cover page of the Prospectus. The foregoing indemnity agreement is
in addition to any liability that the Selling Stockholders may otherwise have to any Underwriter or any affiliate, director, officer, employee or controlling person of that Underwriter. Notwithstanding the foregoing, such Selling Stockholder shall
be liable under this Section&nbsp;9(b) only to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in any
Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any such amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials, any Blue Sky Application or any
&#147;free writing prospectus&#148; (as defined in Rule 405 under the Securities Act) in reliance upon and in conformity with the Selling Stockholder Information, or arises out of, or is based upon, any untrue statement or alleged untrue statement
or omission or alleged omission made in any Selling Stockholder Free Writing Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Each Underwriter,
severally and not jointly, shall indemnify and hold harmless the Company, the Selling Stockholders, their respective directors and officers and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act
or Section&nbsp;20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the Company or any such director, officer or controlling person may become subject, under the
Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the
Registration Statement, the Prospectus, any Issuer Free </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials, or (ii)&nbsp;the omission or alleged omission to state in any Preliminary Prospectus, the Registration
Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, but in
each case only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information concerning such Underwriter furnished to the Company through the
Representatives by or on behalf of that Underwriter specifically for inclusion therein, which information is limited to the information set forth in Section&nbsp;9(f). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Promptly after receipt by an indemnified party under this Section&nbsp;9 of notice of any claim or the commencement
of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;9, notify the indemnifying party in writing of the claim or the commencement of that action;
<I>provided</I>,<I> however</I>, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section&nbsp;9 except to the extent it has been materially prejudiced (through the forfeiture of
substantive rights and defenses) by such failure and, <I>provided</I>, <I>further</I>, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this
Section&nbsp;9. If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall retain counsel reasonably satisfactory to the indemnified party to represent
the indemnified party and shall pay the reasonably incurred fees and expenses of such counsel related to such claim or action. In any such claim or action, the indemnified party shall have the right to employ counsel to represent jointly the
indemnified party and those other indemnified parties and their respective directors, officers, employees and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought under this
Section&nbsp;9 if (i)&nbsp;the indemnified party and the indemnifying party shall have so mutually agreed; (ii)&nbsp;the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party;
(iii)&nbsp;the indemnified party and its directors, officers, employees and controlling persons shall have reasonably concluded that there may be legal defenses available to them that are different from or in addition to those available to the
indemnifying party; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the indemnified parties or their respective directors, officers, employees or controlling persons, on the one hand, and the
indemnifying party, on the other hand, and representation of both sets of parties by the same counsel would be inappropriate due to actual or potential differing interests between them, and in any such event the reasonable and documented fees and
expenses of such separate counsel shall be paid by the indemnifying party. It is understood and agreed that the indemnifying party shall not, in connection with any action or claim or related action or claim in the same jurisdiction, be liable for
the fees and expenses of more than one separate firm (in addition to any local counsel) for all indemnified parties, except as provided for in this Section&nbsp;9. No indemnifying party shall (x)&nbsp;without the prior written
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
consent of the indemnified parties (which consent shall not be unreasonably withheld, conditioned or delayed), settle or compromise or consent to the entry of any judgment with respect to any
pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such
settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and does not include a statement as to, or an admission of fault, culpability or a
failure to act by or on behalf of any indemnified party, or (y)&nbsp;be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably withheld), but if settled with the consent of the
indemnifying party or if there be a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or
judgment. No indemnified party shall, without the written consent of the indemnifying party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of
which indemnification or contribution may be sought hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;If the indemnification provided for in this
Section&nbsp;9 shall for any reason be unavailable to or insufficient to hold harmless an indemnified party under Section&nbsp;9(a), 9(b) or 9(c) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to
therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof,
(i)&nbsp;in such proportion as shall be appropriate to reflect the relative benefits received by the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, from the offering of the Stock, or (ii)&nbsp;if the
allocation provided by clause (i)&nbsp;above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company and the
Selling Stockholders, on the one hand, and the Underwriters, on the other hand, with respect to the statements or omissions that resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable
considerations. The relative benefits received by the Company and the Selling Stockholders, on the one hand, and the Underwriters, on the other hand, with respect to such offering shall be deemed to be in the same proportion as the total net
proceeds from the offering of the Stock purchased under this Agreement (before deducting expenses) received by the Company and the Selling Stockholders, as set forth in the table on the cover page of the Prospectus, on the one hand, and the total
underwriting discounts and commissions received by the Underwriters with respect to the shares of the Stock purchased under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be
determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Selling Stockholders, on the one hand, or the
Underwriters, on the other hand, the intent of the parties and their relative knowledge, access to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
information and opportunity to correct or prevent such statement or omission. The Company, the Selling Stockholders and the Underwriters agree that it would not be just and equitable if
contributions pursuant to this Section&nbsp;9(e) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable
considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section&nbsp;9(e) shall be deemed to include, for
purposes of this Section&nbsp;9(e), any documented out of pocket legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this
Section&nbsp;9(e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Stock exceeds
the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of
Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute as provided in this Section&nbsp;9(e) are several
in proportion to their respective underwriting obligations and not joint. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;It is understood and agreed upon that
the statements regarding the concession and reallowance figures and the paragraph relating to stabilization by the Underwriters appearing under the caption &#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus are
correct and constitute the only information concerning such Underwriters furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in any Preliminary Prospectus, the Registration Statement, the Prospectus,
any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">10.&#8195;<I>Defaulting
Underwriters</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;If, on any Delivery Date, any Underwriter defaults in its obligations to purchase the Stock
that it has agreed to purchase under this Agreement, the remaining <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Stock by the
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Stock, then the Company and the Selling Stockholders shall be entitled to a further period of 36 hours within which to procure other persons
satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Stock on such terms. In the event that within the respective prescribed periods, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT>
Underwriters notify the Company and the Selling Stockholders that they have so arranged for the purchase of such Stock, or the Company and the Selling Stockholders notify the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters that
it has so arranged for the purchase of such Stock, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Selling Stockholders may postpone such Delivery Date for up to seven full business days in order to effect any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">
changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Prospectus or in any other document or arrangement, and
the Company agrees to promptly prepare any amendment or supplement to the Registration Statement, the Prospectus or in any such other document or arrangement that effects any such changes. As used in this Agreement, the term &#147;Underwriter,&#148;
unless the context requires otherwise, includes any party not listed in Schedule I hereto that, pursuant to this Section&nbsp;10, purchases Stock that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;If, after giving effect to any arrangements for the purchase of the Stock of a defaulting Underwriter or Underwriters
by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company and the Selling Stockholders as provided in paragraph (a)&nbsp;above, the total number of shares of the Stock that remains unpurchased does not exceed <FONT
STYLE="white-space:nowrap">one-eleventh</FONT> of the total number of shares of all the Stock, then the Selling Stockholders shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the
total number of shares of Stock that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s pro rata share (based on the total number of shares of Stock that such Underwriter agreed to purchase hereunder) of the Stock of such
defaulting Underwriter or Underwriters for which such arrangements have not been made; <I>provided</I> that the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters shall not be obligated to purchase more than 110% of the total number
of shares of Stock that it agreed to purchase on such Delivery Date pursuant to the terms of Section&nbsp;3. Nothing herein shall relieve a defaulting Underwriter from liability for its default. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;If, after giving effect to any arrangements for the purchase of the Stock of a defaulting Underwriter or Underwriters
by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company and the Selling Stockholders as provided in paragraph (a)&nbsp;above, the total number of shares of Stock that remains unpurchased exceeds <FONT
STYLE="white-space:nowrap">one-eleventh</FONT> of the total number of shares of all the Stock, or if the Selling Stockholders shall not exercise the right described in paragraph (a)&nbsp;above, then this Agreement shall terminate without liability
on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the Company will continue
to be liable for the payment of expenses as set forth in Sections&nbsp;7 and 12 and except that the provisions of Section&nbsp;10 shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">11.&#8195;<I>Termination</I><I>.</I> The
obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the Company and the Selling Stockholders prior to delivery of and payment for the Firm Stock if, prior to that time, any of the
events described in Section&nbsp;8(j), 8(k) and 8(l) shall have occurred or if the Underwriters shall decline to purchase the Stock for any reason permitted under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">12.&#8195;<I>Reimbursement of Underwriters</I><I>&#146;</I><I> Expenses</I><I>.</I> If
(a)&nbsp;the Selling Stockholders shall fail to tender the Stock for delivery to the Underwriters for any reason, or (b)&nbsp;the Underwriters shall decline to purchase the Stock for any reason permitted under this Agreement, the Company will
reimburse the Underwriters for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including fees and disbursements of counsel for the Underwriters) incurred by the
Underwriters in connection with this Agreement and the proposed purchase of the Stock, and upon demand the Company shall pay the full amount thereof to the Representatives. If this Agreement is terminated pursuant to Section&nbsp;10 by reason of the
default of one or more Underwriters, neither the Company nor the Selling Stockholders shall be obligated to reimburse any defaulting Underwriter on account of those expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">13.&#8195;<I>Research Analyst Independence. </I>The Company acknowledges that the Underwriters&#146; research analysts and research
departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters&#146; research analysts may hold views and make statements or
investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company and the Selling Stockholders hereby waive and
release, to the fullest extent permitted by law, any claims that the Company or the Selling Stockholders may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their
independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company or the Selling Stockholders by such Underwriters&#146; investment banking divisions. The Company and
the Selling Stockholders acknowledge that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers
and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">14.&#8195;<I>No Fiduciary Duty</I>. The Company and each Selling Stockholder acknowledges and agrees that in connection with this offering,
sale of the Stock or any other services the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise and are not providing a recommendation or investment advice, between the parties or
any oral representations or assurances previously or subsequently made by the Underwriters: (a)&nbsp;no fiduciary or agency relationship between the Company, such Selling Stockholder, and any other person, on the one hand, and the Underwriters, on
the other hand, exists; (b)&nbsp;the Underwriters are not acting as advisors, expert or otherwise, to either the Company or such Selling Stockholder, including, without limitation, with respect to the determination of the public offering price of
the Stock, and such relationship between the Company and such Selling Stockholder, on the one hand, and the Underwriters, on the other hand, is entirely and solely commercial, based on arms-length negotiations and, as such, not intended for use by
any individual for personal, family or household purposes; (c)&nbsp;any duties and obligations that the Underwriters may have to the Company or such Selling Stockholder shall be limited to those duties and obligations specifically stated herein;
(d)&nbsp;the Underwriters and their respective affiliates may have interests that differ from those of the Company and such Selling Stockholder; (e)&nbsp;the purchase and sale of the Stock pursuant to this Agreement does not constitute a
recommendation, investment advice, or solicitation of any action </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Underwriters and (f)&nbsp;none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice or solicitation
of any action by the Underwriters with respect to any entity or natural person. The Company and such Selling Stockholder hereby (x)&nbsp;waive any claims that the Company or such Selling Stockholder may have against the Underwriters with respect to
any breach of fiduciary duty in connection with this offering and (y)&nbsp;agree that none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice or solicitation
of any action by the Underwriters with respect to any entity or natural person. Each of the Company and such Selling Stockholder has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate.
Moreover, each Selling Shareholder acknowledges and agrees that, although the Representatives may be required or choose to provide certain Selling Stockholders with certain Regulation Best Interest and Form CRS disclosures in connection with the
offering, the Representatives and the other Underwriters are not making a recommendation to any Selling Stockholder to participate in the offering, enter into a <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement, or sell any Stock
at the price determined in the offering, and nothing set forth in such disclosures is intended to suggest that the Representatives or any Underwriter is making such a recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">15.&#8195;<I>Notices, etc</I><I>.</I> All statements, requests, notices and agreements hereunder shall be in writing, and: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;if to the Underwriters, shall be delivered or sent by mail or facsimile transmission to Goldman Sachs&nbsp;&amp; Co.
LLC, 200 West Street, New York, New York 10282, Attention: Registration Department; and J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212) <FONT STYLE="white-space:nowrap">622-8358),</FONT> Attention: Equity
Syndicate Desk; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;if to the Company, shall be delivered or sent by mail or facsimile transmission to TD SYNNEX
Corporation, 16202 Bay Vista Drive, Clearwater, FL 33760, Attention: David R. Vetter, Chief Legal Officer, with a copy (which shall not constitute notice) to: Pillsbury Winthrop Shaw Pittman LLP, 2550 Hanover Street, Palo Alto, CA 94304-1115,
Attention: Allison M. Leopold Tilley, Esq. and Davina K. Kaile, Esq.; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;if to the Apollo Entities, shall be
delivered or sent by mail or facsimile transmission to 9 West 57<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street, 42<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP> Floor, New York, New York 10019, with a copy to Paul, Weiss,
Rifkind, Wharton&nbsp;&amp; Garrison LLP, 1285 Avenue of the Americas, New York, NY 10019-6064, Attention: Brian M. Janson, Esq.; Christodoulos Kaoutzanis, Esq., and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;if to the MiTAC Entities, shall be delivered or sent by mail, facsimile or email transmission to
&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;, facsimile &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;, Attention:
&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;), &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;) and &#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;) and a copy sent to FreelandLaw LLP, 101 Mission
Street Suite 1000, San Francisco, CA 94105, facsimile <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-415-495-4332,</FONT></FONT></FONT> Attention: Frank F. Huang, Esq. (huang@freelandlaw.com).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof. The
Company and the Selling Stockholders shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by the Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">16.&#8195;<I>Persons Entitled to Benefit of Agreement</I>. This Agreement shall inure to the benefit of and be binding upon the Underwriters,
the Selling Stockholders, the Company and their respective personal representatives and successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that (a)&nbsp;the representations,
warranties, indemnities and agreements of the Company and the Selling Stockholders contained in this Agreement shall also be deemed to be for the benefit of the directors, officers, affiliates and employees of the Underwriters and each person or
persons, if any, who control any Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and (b)&nbsp;the indemnity agreement of the Underwriters contained in Section&nbsp;9(c) of this
Agreement shall be deemed to be for the benefit of the directors of the Company, the officers of the Company who have signed the Registration Statement and any person controlling the Company within the meaning of Section&nbsp;15 of the Securities
Act or Section&nbsp;20 of the Exchange Act. Nothing in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this Section&nbsp;16, any legal or equitable right, remedy or claim under or in respect
of this Agreement or any provision contained herein. No purchaser of any of the Stock from any Underwriter shall be deemed a successor or assign by reason merely of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">17.&#8195;<I>Survival.</I> The respective indemnities, rights of contributions, representations, warranties and agreements of the Company, the
Selling Stockholders and the Underwriters contained in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Stock and shall remain in full force and effect,
regardless of any investigation made by or on behalf of any of them or any person controlling any of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">18.&#8195;<I>Definition of the
Terms </I><I>&#147;</I><I>Business Day</I><I>&#148;</I><I>, </I><I>&#147;</I><I>Affiliate</I><I>&#148;</I><I> and </I><I>&#147;</I><I>Subsidiary</I><I>&#148;</I>. For purposes of this Agreement, (a) &#147;<B><I>business day</I></B>&#148; means each
Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which banking institutions in New York are generally authorized or obligated by law or executive order to close, and (b) &#147;<B><I>affiliate</I></B>&#148; and
&#147;<B><I>subsidiary</I></B>&#148; have the meanings set forth in Rule&nbsp;405 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">19.&#8195;<I>Governing
Law</I>. This Agreement, any transaction contemplated by this Agreement and any claim or controversy or dispute arising under or related thereto shall be governed by and construed in accordance with the laws of the State of New York without regard
to conflict of laws principles that would result in the application of any other law than the laws of the State of New York (other than Section&nbsp;5-1401 of the General Obligations Law). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">20.&#8195;<I>Submission to Jurisdiction</I>. The MiTAC Entities hereby submit to the
exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The MiTAC
Entities waive any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The MiTAC Entities agree that final judgment in any such suit, action or proceeding brought in such court shall be
conclusive and binding upon the MiTAC Entities, and may be enforced in any court to the jurisdiction of which the MiTAC Entities are subject by a suit upon such judgment. The MiTAC Entities irrevocably appoint Frank F. Huang, located 101 Mission
Street, Suite 1000, San Francisco, CA 94105, as its authorized agent upon which process may be served in any such suit or proceeding, and agrees that service of process upon such authorized agent, and written notice of such service to the MiTAC
Entities by the person serving the same to the address provided in this Section, shall be deemed in every respect effective service of process upon the MiTAC Entities in any such suit or proceeding. The MiTAC Entities hereby represent and warrant
that such authorized agent has accepted such appointment and has agreed to act as such authorized agent for service of process. The MiTAC Entities further agree to take any and all action as may be necessary to maintain such designation and
appointment of such authorized agent in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">21.&#8195;<I>Waiver of Immunity</I>. To the extent that the MiTAC Entities
have or hereafter may acquire any immunity (sovereign or otherwise) from jurisdiction of any court of (i)&nbsp;Taiwan, BVI, or any political subdivision thereof, (ii)&nbsp;the United States or the State of New York, (iii)&nbsp;any jurisdiction in
which it owns or leases property or assets or from any legal process (whether through service of notice, attachment prior to judgment, attachment in aid of execution, execution, <FONT STYLE="white-space:nowrap">set-off</FONT> or otherwise) with
respect to themselves or their respective property and assets or this Agreement, the MiTAC Entities hereby irrevocably waive such immunity in respect of their obligations under this Agreement to the fullest extent permitted by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">22.&#8195;<I>Tax Indemnity</I>. The MiTAC Entities will indemnify and hold harmless the Underwriters against any documentary, stamp,
registration or similar issuance tax, including any interest and penalties, on the sale of the Stock by such MiTAC Entity to the Underwriters and on the execution and delivery of this Agreement. All payments to be made by the MiTAC Entities
hereunder shall be made without withholding or deduction for or on account of any present or future Taiwan or BVI taxes, duties or governmental shares whatsoever unless the Company is compelled by law to deduct or withhold such taxes, duties or
charges. In that event, the MiTAC Entities shall pay such additional amounts as may be necessary in order to ensure that the net amounts received after such withholding or deductions shall equal the amounts that would have been received if no
withholding or deduction has been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">23.&#8195;<I>Judgment Currency</I>. The MiTAC Entities agree to indemnify each Underwriter, each
employee, officer and director of each Underwriter, and each person, if any, who controls any Underwriter within the meaning of the Act and each broker-dealer or other affiliate of any Underwriter, against any loss incurred as a result of any
judgment or order being given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the &#147;<U>judgment currency</U>&#148;) other than U.S. dollars and as a result of any variation as between
(i)&nbsp;the rate of exchange at which the U.S. dollar amount is converted into the judgment currency for the purpose of such judgment or order, and (ii)&nbsp;the rate of exchange at which such indemnified
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
person is able to purchase U.S. dollars with the amount of the judgment currency actually received by the indemnified person. The foregoing indemnity shall constitute a separate and independent
obligation of the MiTAC Entities and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term &#147;rate of exchange&#148; shall include any premiums and costs of exchange payable in connection with
the purchase of, or conversion into, the relevant currency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">24.&#8195;<I>Waiver of Jury Trial</I>. The Company and the Underwriters
hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">25.&#8195;<I>Counterparts</I><I>.</I> This Agreement may be executed in one or more counterparts and, if executed in more than one
counterpart, the executed counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic
signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman">26.&#8195;<I>Headings</I><I>.</I>
The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&#8195;<I>Recognition of the U.S. Special Resolution Regimes.</I><I> </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;In the event that any Underwriters that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime,
the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and
any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;In the event
that any Underwriters that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are
permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this Section, a &#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in
accordance with, 12 U.S.C. &#167; 1841(k). &#147;Covered Entity&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered
bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#147;Default Right&#148; has the meaning
assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;U.S. Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the
regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the agreement among the Company, the Selling
Stockholders and the Underwriters, please indicate your acceptance in the space provided for that purpose below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TD SYNNEX CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marshall Witt</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Marshall Witt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AP IX Tiger Holdings, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML)&nbsp;GP, LLC,<BR><I>its general partner</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: AP IX Tiger Holdings GP, LLC,<BR><I>its sole member</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Elworth</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James Elworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> II, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: AP IX Tiger Holdings GP, LLC,<BR><I>its general partner</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Elworth</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James Elworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML), L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: AP IX Tiger Holdings GP, LLC,<BR><I>its general partner</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Elworth</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James Elworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>S</I><I>ignature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Tiger Parent Holdings, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Tiger Parent Holdings GP, LLC,<BR><I>its general partner</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Elworth</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>James Elworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MiTAC International Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Peer Developments Ltd.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Matthew Feng Chiang Miau</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Frank F. Huang</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frank F. Huang</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>As <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-in-Fact</FONT></FONT> acting on behalf of each of the above.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. Morgan Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For themselves and as Representatives of the several Underwriters named in Schedule I hereto</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Elizabeth Wood</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Elizabeth Wood</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By J.P. Morgan Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eugene Sohn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eugene Sohn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>Shares of<BR>Firm Stock</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>Shares of<BR>Option&nbsp;Stock</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">506,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">506,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,012,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE II </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Selling Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares<BR>of Firm Stock</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number of<BR>Shares of<BR>Option&nbsp;Stock</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="8" ALIGN="center"><FONT STYLE="font-size:10pt"><B>&#147;</B><B><I>Apollo Entities</I></B><B>&#148;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AP IX Tiger Holdings, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,651,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">554,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> II, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">803,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AP IX Tiger <FONT STYLE="white-space:nowrap">Co-Invest</FONT> (ML), L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,381,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209,805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tiger Parent Holdings, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="8" ALIGN="center"><FONT STYLE="font-size:10pt"><B>&#147;</B><B><I>MiTAC Entities</I></B><B>&#148;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MiTAC International Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">460,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peer Developments Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">335,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Feng Chiang Miau</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,012,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE IV </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INFORMATION OTHER THAN THE PRICING PROSPECTUS THAT COMPRISE THE </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PRICING DISCLOSURE PACKAGE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Firm Stock:
6,750,000 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Optional Stock: 1,012,500 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Price to
Public: $96.00 per share </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of Repurchase Shares purchased on the Initial Delivery Date by the Company is 2,750,000. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE V </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ISSUER FREE WRITING PROSPECTUSES &#150; ROAD SHOW MATERIALS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE VI </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ISSUER FREE WRITING PROSPECTUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SCHEDULE VII </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WRITTEN <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">TESTING-THE-WATERS</FONT></FONT> COMMUNICATIONS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>snx-20231010.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/13/2023 9:15:17 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:snx="http://www.synnex.com/20231010"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.synnex.com/20231010"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="snx-20231010_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="snx-20231010_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>snx-20231010_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/13/2023 9:15:17 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>snx-20231010_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/13/2023 9:15:17 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="snx-20231010.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140383125117200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TD SYNNEX CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001177394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 10,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2703333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">44201 Nobel Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">656-3333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d438723d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snx-20231010.xsd" xlink:type="simple"/>
    <context id="duration_2023-10-10_to_2023-10-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001177394</identifier>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-10-10_to_2023-10-10"
      id="Hidden_dei_EntityRegistrantName">TD SYNNEX CORP</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-10-10_to_2023-10-10">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-10-10_to_2023-10-10"
      id="Hidden_dei_EntityCentralIndexKey">0001177394</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-10-10_to_2023-10-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-10-10_to_2023-10-10">2023-10-10</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-10-10_to_2023-10-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-10-10_to_2023-10-10">001-31892</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-10-10_to_2023-10-10">94-2703333</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-10-10_to_2023-10-10">44201 Nobel Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-10-10_to_2023-10-10">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-10-10_to_2023-10-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-10-10_to_2023-10-10">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-10-10_to_2023-10-10">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-10-10_to_2023-10-10">656-3333</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-10-10_to_2023-10-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-10-10_to_2023-10-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-10-10_to_2023-10-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-10-10_to_2023-10-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-10-10_to_2023-10-10">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-10-10_to_2023-10-10">SNX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-10-10_to_2023-10-10">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-10-10_to_2023-10-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( ," 35>7BKL<P
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( ," 35<'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ P(!-5ZNF
M/'WN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ P(!-5YE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " # @$U7I"ZGGD0$  "#
M$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ P(!-5Y^@&_"Q @  X@P   T              ( !APP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " # @$U7EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d438723d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d438723d8k.htm">d438723d8k.htm</File>
    <File>snx-20231010.xsd</File>
    <File>snx-20231010_lab.xml</File>
    <File>snx-20231010_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d438723d8k.htm": {
   "nsprefix": "snx",
   "nsuri": "http://www.synnex.com/20231010",
   "dts": {
    "inline": {
     "local": [
      "d438723d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "snx-20231010.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "snx-20231010_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snx-20231010_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2022": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "report": {
    "R1": {
     "role": "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-10-10_to_2023-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d438723d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-10-10_to_2023-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d438723d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.synnex.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-256083-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-256083-xbrl.zip
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M;9Z<5,]JJ_B5E_9.L"$3H%N9A&=4- VI= +,192.:J!^N\Q)9SQQD;75NY%
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MP#"I:I;%%YK763&M>CJ>Q068/&6M>C[8H18//%_,6]Q^DDU#G8=9!Y]-!'_
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MV[ 1-Y><%G\C0\=%Z78DB+K//!NVT^>PH^/ ]:G'>"#=.9$@2W(X5SW##GP
M=% BIC0UMB22BP$,!+SBS:.V(7BY?(H=T<P[4O7+IY2HHJ[-K#!Z:J@Q<$MS
M5Y*Q**7ZB7E,@$'H>#!5H$]9FJ5*22_OJ+&6\8X?[=@?U'&/O?6%![\:*BR%
M$KM9\F7C''KF'S98OC :^'">:>'6:=Y_",<'5L'P,?#":$L^V0<<<.X.*'")
M#\R*.)^=U&KGJ\IYF[E7N"<X@*0WG3Q9@2\5N^2N0GH  9($(9/H/!#DJ1L
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MD[^J @Y_ ^\JQZ/L_+S.S[,VQS4Y:ZEA:ZGSVI^+>LD[BVP)/RSKPM\^>MK
M'LC>H/.&Q65U<IDM@,;_]>3XY.0T6>4UORJZ06NI='8)N\//K[?);GSJ>*0?
MJ\5]N 5[Y?3X B@5S@:)M,4'P<_Z0<_,W\*GS*LZN;JHELFF6B>XM6S:(CT
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M6KAC\JT_;IXN#*O=,RO_&BG;1Q;P&3!#G<_!&D3Y0A;A[LH+P]&@O4!YN/@
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MBHD1CMD*I/(E_!M%L/T;\AA^R8]!?DH6;WS"09VP0&M[AH=L<W)_#Y+.UZU
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M2?B9R!?Z(WFR@4\U+D8\)/_NP!'(M6KKN03Q^,G4$WDNOZ*:.HRP+5'/([>
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MW=",3VYFQ7?-]Z !7OBXWY@W")#)K<QZK$:ZC5W_)0:!OOL:!-JKC/[P48-
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MB\U_OHA^XSSJPX1PC_"$V]HT7C,5VZ#1T#->3L1$D/!.RA%T#=H<?P9[R+T
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M)AA,/]WA=L\%WC ,&P4HUZ$\2N:(HOV@%5I*I)T5X7\K&XZ.:8\Z)>%PS,0
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MTB?IOM$,R[?TXKZ_-:272-7P:+M#K+@QT? BR6/294JF@G"4Z<AA7>TQ I3
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M%!95!7960Q6H,/KA_H<PM:?UV$1+>\G#F]R,\T.L/I?%21@^!@B*=<(5?#A
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M52=XU/@69[/N&<Y.FF*2]?8#[X\A/@]E:8"J8RPU[1#&?B+LXM<G-9)+\2J
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M              "  0    !D-#,X-S(S9#AK+FAT;5!+ 0(4 Q0    ( ,"
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G+3(P,C,Q,#$P7W!R92YX;6Q02P4&      4 !0 \ 0  X[,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
